296 related articles for article (PubMed ID: 15701436)
21. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
Doria C; Jain AK; Scott VL; Gruttadauria S; Marino IR; Doyle HR; Fung JJ
Exp Clin Transplant; 2003 Jun; 1(1):48-55. PubMed ID: 15859907
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
Boillot O; Mayer DA; Boudjema K; Salizzoni M; Gridelli B; Filipponi F; Trunecka P; Krawczyk M; Clavien PA; Ducerf C; Margarit C; Margreiter R; Pallardo JM; Hoeckerstedt K; Pageaux GP
Liver Transpl; 2005 Jan; 11(1):61-7. PubMed ID: 15690537
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan.
Wang CH; Ko WJ; Chou NK; Wang SS
Transplant Proc; 2004 Oct; 36(8):2384-5. PubMed ID: 15561256
[TBL] [Abstract][Full Text] [Related]
24. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
[TBL] [Abstract][Full Text] [Related]
25. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
[TBL] [Abstract][Full Text] [Related]
26. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
[TBL] [Abstract][Full Text] [Related]
27. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.
Castel MA; Farrero M; Vallejos I; Cardona M; Regueiro A; Pérez-Villa F
Transplant Proc; 2011; 43(6):2244-6. PubMed ID: 21839245
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study.
Lerut J; Mathys J; Verbaandert C; Talpe S; Ciccarelli O; Lemaire J; Bonaccorsi-Riani E; Vanthuyne V; Hetsch N; Roggen F; Reyck CD; Goffette P; Latinne D; Orlando G; Rahier J; Sempoux C; Wallemacq P; Laterre PF; Gianello P
Ann Surg; 2008 Dec; 248(6):956-67. PubMed ID: 19092340
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
[TBL] [Abstract][Full Text] [Related]
31. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
32. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[TBL] [Abstract][Full Text] [Related]
33. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
[TBL] [Abstract][Full Text] [Related]
34. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
[TBL] [Abstract][Full Text] [Related]
35. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
36. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
Reichenspurner H
J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
Krämer BK; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Ortuño J; Sester U; Kunzendorf U; Dietl KH; Bonomini V; Rigotti P; Ronco C; Tabernero JM; Rivero M; Banas B; Mühlbacher F; Arias M; Montagnino G;
Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740
[TBL] [Abstract][Full Text] [Related]
38. Ten- and 20-year survivors of pediatric orthotopic heart transplantation.
Ross M; Kouretas P; Gamberg P; Miller J; Burge M; Reitz B; Robbins R; Chin C; Bernstein D
J Heart Lung Transplant; 2006 Mar; 25(3):261-70. PubMed ID: 16507417
[TBL] [Abstract][Full Text] [Related]
39. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
40. Comparison between effects of cyclosporine and tacrolimus on glomerular filtration rate in pediatric post-orthotopic liver transplant patients.
Loo RM; Ariyarajah V; Oh C; Shen L; Aw MM; Prabhakaran K
Pediatr Transplant; 2006 Feb; 10(1):55-9. PubMed ID: 16499588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]